Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$36.42 - $57.0 $1.71 Million - $2.68 Million
-47,035 Closed
0 $0
Q2 2020

Jul 30, 2020

SELL
$39.26 - $52.73 $2.87 Million - $3.86 Million
-73,181 Reduced 60.87%
47,035 $2.28 Million
Q1 2020

May 07, 2020

SELL
$31.65 - $46.87 $5,380 - $7,967
-170 Reduced 0.14%
120,216 $5.08 Million
Q4 2019

Feb 07, 2020

BUY
$36.21 - $51.4 $838,152 - $1.19 Million
23,147 Added 23.8%
120,386 $5.15 Million
Q3 2019

Nov 12, 2019

BUY
$22.22 - $44.01 $1.41 Million - $2.79 Million
63,493 Added 188.15%
97,239 $3.5 Million
Q2 2019

Jul 26, 2019

SELL
$23.32 - $28.12 $612,453 - $738,515
-26,263 Reduced 43.77%
33,746 $902,000
Q1 2019

May 03, 2019

SELL
$16.17 - $27.38 $627,347 - $1.06 Million
-38,797 Reduced 39.27%
60,009 $1.61 Million
Q4 2018

Feb 12, 2019

BUY
$14.32 - $22.92 $84,788 - $135,709
5,921 Added 6.37%
98,806 $1.6 Million
Q3 2018

Oct 31, 2018

BUY
$13.03 - $21.81 $1.21 Million - $2.03 Million
92,885 New
92,885 $1.93 Million
Q1 2018

Apr 26, 2018

SELL
$22.47 - $32.33 $802,201 - $1.15 Million
-35,701 Closed
0 $0
Q4 2017

Jan 31, 2018

BUY
$26.84 - $39.14 $182,028 - $265,447
6,782 Added 23.45%
35,701 $1.08 Million
Q3 2017

Nov 13, 2017

BUY
$29.49 - $38.37 $852,821 - $1.11 Million
28,919
28,919 $1.09 Million

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.65B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.